Optimal timing maximises Paxlovid benefits for treating COVID-19
4/23/2024
Researchers develop a new way to safely boost immune cells to fight cancer
4/19/2024
How the Birmingham Drug Discovery Hub created an investment-ready 'drug library'
4/18/2024
Development of a pharmaceutical database as an aid to the nonclinical detection of drug-induced cardiac toxicity
4/17/2024
Test facility management: Responsibilities and paradigms of a new era
4/17/2024
Common HIV treatments may aid Alzheimer's disease patients
4/17/2024
Next-generation treatments hitch a ride into cancer cells
4/15/2024
Groundbreaking treatment approach shows promise in hard-to-treat cancers
4/12/2024
This outdated diabetes drug still has something to offer
4/11/2024
New drug prevents flu-related inflammation and lung damage
4/10/2024
Swapping red meat for herring/sardines could save up to 750,000 lives/year in 2050
4/9/2024
Does cannabis use affect cognitive decline?
4/8/2024
Novel biological mechanism discovered that could lead to new treatments for neurological disorders, cancers
4/5/2024
Development, validation, and clinical application of a UPLC-MS/MS method for omadacycline determination in human serum
4/4/2024
New study paves the way for precision drugs to treat blood cancers
4/4/2024
Johns Hopkins investigators develop novel treatment for T-cell leukemias and lymphomas
4/3/2024
Scientists link certain gut bacteria to lower heart disease risk
4/2/2024
ASPET joined the College of Problems of Drug Dependence statement on psychedelics
4/1/2024
Novel method for determination of colistin sulfate in human plasma by high-performance liquid chromatography-tandem mass spectrometry and its clinical applications in critically ill patients
3/29/2024
Letters and medicine recalls sent to healthcare professionals in February 2024
3/27/2024
Editorial Board
3/26/2024
Evaluation of the translation of multiple cardiovascular regulatory mechanisms in the anesthetized dog
3/12/2024
Improved seizure liability detection by combining rat hippocampal brain slice electrophysiology with in vivo behavior observation following intracerebroventricular drug administration
3/2/2024
Virtual clinical QT exposure-response studies – A translational computational approach
3/2/2024
ASPET Comment Letter to NIST RFI Regarding the Draft Interagency Guidance Framework for Considering the Exercise of March-In Rights
2/20/2024
Codeine linctus (codeine oral solutions): reclassification to prescription-only medicine
2/20/2024
Pseudoephedrine: very rare risk of posterior reversible encephalopathy syndrome (PRES) and reversible cerebral vasoconstriction syndrome (RCVS)
2/20/2024
Letters and medicine recalls sent to healthcare professionals in January 2024
2/20/2024
The visual field-testing maze and vision maze: Feasible techniques to evaluate visual field loss in animals
2/18/2024
ASPET Comment Letter to NIH OLAW RFI on on Clarification of Animal Activities Exempt from the PHS Policy Requirements for IACUC Review
2/7/2024
ASPET Comment Letter to NIH OLAW RFI on Flexibilities for Streamlining IACUC Review of Protocols and Significant Changes
2/7/2024
ASPET Comment Letter to NIH RFI on Inviting Comments and Suggestions on Updating the NIH Mission Statement
2/7/2024
ASPET Comment Letter to NIH's OLAW RFI on an Update to the Current OLAW Guidance Disclaimer
2/7/2024
ASPET joined over a 1,000 other organizations to urge Congress to finalize FY24 and avoid any additional CRs
2/5/2024
ASPET Comment Letter to NIH on DRAFT of Scientific Integrity Policy of the National Institutes of Health
2/5/2024
ASPET Comment Letter to NIH RFI on NIH Plan to Enhance Public Access to the Results of NIH-Supported Research
2/5/2024
ASPET Comment Letter to DEA on Schedules of Controlled Substances: Placement of 2,5- dimethoxy-4-iodoamphetamine (DOI) and 2,5-dimethoxy-4- chloroamphetamine (DOC) in Schedule I
1/29/2024
ASPET Comment Letter to NIH RFI on Re- envisioning U.S. Postdoctoral Research Training and Career Progression within the Biomedical Research Enterprise
1/22/2024
Valproate (Belvo, Convulex, Depakote, Dyzantil, Epilim, Epilim Chrono or Chronosphere, Episenta, Epival, and Syonell▼): new safety and educational materials to support regulatory measures in men and women under 55 years of age
1/22/2024
Fluoroquinolone antibiotics: must now only be prescribed when other commonly recommended antibiotics are inappropriate
1/22/2024
Omega-3-acid ethyl ester medicines (Omacor/Teromeg 1000mg capsules): dose-dependent increased risk of atrial fibrillation in patients with established cardiovascular diseases or cardiovascular risk factors
1/22/2024
Letters and medicine recalls sent to healthcare professionals in December 2023
1/22/2024
Aripiprazole (Abilify and generic brands): risk of pathological gambling
12/18/2023
Vitamin B12 (hydroxocobalamin, cyanocobalamin): advise patients with known cobalt allergy to be vigilant for sensitivity reactions
12/18/2023
Letters and medicine recalls sent to healthcare professionals in November 2023
12/18/2023
Ozempic▼(semaglutide) and Saxenda (liraglutide): vigilance required due to potentially harmful falsified products
11/23/2023
Nirmatrelvir, ritonavir (Paxlovid▼): be alert to the risk of drug interactions with ritonavir
11/23/2023
E-cigarette use or vaping: reminder to remain vigilant for suspected adverse reactions and safety concerns and report them to the Yellow Card scheme
11/23/2023
Letters and medicine recalls sent to healthcare professionals in October 2023
11/23/2023
Isotretinoin (Roaccutane▼): introduction of new safety measures, including additional oversight of the initiation of treatment for patients under 18 years of age
10/31/2023